May 16th 2024
Frontline treatment with pembrolizumab plus trastuzumab/chemotherapy significantly and meaningfully improved overall survival in HER2-positive, unresectable or metastatic gastric/GEJ cancer.
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®
View More
8th Annual School of Nursing Oncology™
August 10, 2024
Register Now!
2024 International Symposium of Gastrointestinal Oncology (ISGIO)
October 11-12, 2024
Register Now!
Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
View More
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape
View More
The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…
View More
Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®
View More
Screening Saves: Know Your Options And Talk to Your Doctor
March 21st 2017On March 21, at 9 PM EST, the #CureConnect tweetchat will be focusing on screening and prevention. Sharyn Worrall, Patient Education Manager for FightCRC will be comoderating on this topic, which is especially important for colorectal cancer.
Can Online Searches Help Identify Pancreatic Cancer at an Earlier Stage?
September 1st 2016Researchers analyzed Bing.com search logs to identify those recently diagnosed with pancreatic cancer. Through symptom patterns expressed as searches, they were able to identify 5% to 15% of pancreatic cancer cases.
Study Calls for Interventions to Increase Colorectal Cancer Screening in Hispanic Men
August 28th 2016Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for one group—Hispanic men—rates have remained essentially unchanged, and a new study suggests that lower rates of screening may be the chief driver of this disparity.
Obesity More Prevalent in Survivors, Especially Those Who Had Breast or Colorectal Cancer
August 25th 2016A large, population-based study found that obesity more prevalent in patients with a history of cancer than in the general population, suggesting an important area of focus and a need for improved weight management and control programs targeted at survivors’ specific needs.
Symptom Burden Higher in Newly Diagnosed Patients Reporting Financial Strain
March 25th 2016A study published by researchers at the Dana Farber-Cancer Institute recently discovered that financial status plays a large role in the level of symptom burden and quality of life for patients newly diagnosed with lung or colorectal cancer.
Racial Disparities Persist in Breast Cancer for Women and Colorectal Cancer in Men
March 1st 2016Racial disparities in mortality for breast cancer have gotten worse in women and persisted for colorectal cancer in men, although progress has been made in closing the mortality gap between blacks and whites for other cancers.
Danielle Novetsky Friedman on Abdominal Radiation and Diabetes Risk
February 1st 2016Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center (MSK), discusses a study investigating the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
Robin Brenner on Side Effects of Onivyde for Pancreatic Cancer
January 29th 2016Robin B. Brenner, RN, CRN, OCN, clinical research nurse, David M. Rubinstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, discusses adverse events associated with Onivyde (irinotecan liposome injection; MM-398) for pancreatic cancer.